A Chinese drug company has been ordered to stop production amid an investigation into allegations that pharmaceutical companies were bribing State Food and Drug Administration officials for approvals, reports said yesterday.
Meanwhile, the Health Ministry issued new rules that would bar drug companies from doing business with Chinese medical institutions and revoke doctors' licenses if they are caught giving or taking bribes or kickbacks, the official Xinhua news agency said yesterday.
Chinese drug companies have been accused of paying off doctors, health officials and hospital staff to buy substandard drugs, leading to deaths and injuries, raising serious questions about the safety of medicines sold and prescribed throughout the country.
Last year, Xinfu, an antibiotic approved by China's State Food and Drug Administration, killed at least 10 people before it was taken off the market, state media said.
Authorities are investigating a former drug administration chief, Zheng Xiaoyu (
Kangliyuan Group, a drug firm based in the eastern city of Hangzhou, was ordered to stop operations because of its alleged links to Zheng, the state-run newspaper China Business News and other reports said.
The reports said that the Communist Party's anti-graft watchdog, the Committee for Discipline Inspection, was investigating.
A statement posted on the company's Web site acknowledged that the company's certificate of "Good Manufacturing Practice" (GMP), which is required for legal production, was temporarily suspended pending the outcome of the investigation. It did not say if the company had stopped production, however, or comment on the allegations.
Zheng, a former pharmaceutical company manager from Hangzhou, was removed from his post after serving eight years as China's top drug official. He was detained last month.
Many of the allegations focus on the awarding of GMP certificates and drug registrations. A corruption agency report cited by China Business News said that a Kangliyuan subsidiary based in southern China's Hainan island was given a GMP certificate in 2002 and was winning approvals for about 100 new drugs a year.
The reports alleged that the company was merely repackaging generic drugs, sometimes adding neutral ingredients.
Last week, China's Food and Drug Administration announced it was investigating Guangdong Bioyee Pharmaceutical, suspected of using illegally procured blood stocks to make immunoglobulin and other drugs, possibly infecting patients with hepatitis C.
On Tuesday, the agency announced that its study had found no cases of acute hepatitis caused by the drug. But some patients had developed hepatitis C antibodies, suggesting the company had used tainted blood to make the product, it said on its Web site.
RETHINK? The defense ministry and Navy Command Headquarters could take over the indigenous submarine project and change its production timeline, a source said Admiral Huang Shu-kuang’s (黃曙光) resignation as head of the Indigenous Submarine Program and as a member of the National Security Council could affect the production of submarines, a source said yesterday. Huang in a statement last night said he had decided to resign due to national security concerns while expressing the hope that it would put a stop to political wrangling that only undermines the advancement of the nation’s defense capabilities. Taiwan People’s Party Legislator Vivian Huang (黃珊珊) yesterday said that the admiral, her older brother, felt it was time for him to step down and that he had completed what he
Taiwan has experienced its most significant improvement in the QS World University Rankings by Subject, data provided on Sunday by international higher education analyst Quacquarelli Symonds (QS) showed. Compared with last year’s edition of the rankings, which measure academic excellence and influence, Taiwanese universities made great improvements in the H Index metric, which evaluates research productivity and its impact, with a notable 30 percent increase overall, QS said. Taiwanese universities also made notable progress in the Citations per Paper metric, which measures the impact of research, achieving a 13 percent increase. Taiwanese universities gained 10 percent in Academic Reputation, but declined 18 percent
UNDER DISCUSSION: The combatant command would integrate fast attack boat and anti-ship missile groups to defend waters closest to the coastline, a source said The military could establish a new combatant command as early as 2026, which would be tasked with defending Taiwan’s territorial waters 24 nautical miles (44.4km) from the nation’s coastline, a source familiar with the matter said yesterday. The new command, which would fall under the Naval Command Headquarters, would be led by a vice admiral and integrate existing fast attack boat and anti-ship missile groups, along with the Naval Maritime Surveillance and Reconnaissance Command, said the source, who asked to remain anonymous. It could be launched by 2026, but details are being discussed and no final timetable has been announced, the source
SHOT IN THE ARM: The new system can be integrated with Avenger and Stinger missiles to bolster regional air defense capabilities, a defense ministry report said Domestically developed Land Sword II (陸射劍二) missiles were successfully launched and hit target drones during a live-fire exercise at the Jiupeng Military Base in Pingtung County yesterday. The missiles, developed by the Chungshan Institute of Science and Technology (CSIST), were originally scheduled to launch on Tuesday last week, after the Tomb Sweeping Day holiday long weekend, but were postponed to yesterday due to weather conditions. Local residents and military enthusiasts gathered outside the base to watch the missile tests, with the first one launching at 9:10am. The Land Sword II system, which is derived from the Sky Sword II (天劍二) series, was turned